Search

everythinglearnresearchcommunity

for

Search:↓

Some hair proteins are specific to hair, while others are also found in skin cells.

PROTAC technology shows promise for cancer treatment but needs more effective E3 ligase recruiters.

The targeted nanohybrids effectively reduced psoriasis symptoms and improved skin health.

Aggressive immunosuppressive treatment improved a woman's severe heart condition linked to autoimmune disease.

Blocking α-toxin helps heal Staphylococcus aureus-infected wounds faster in both normal and diabetic mice, with different effects on their immune responses.

Cow colostrum and milk can effectively produce anti-hair keratin antibodies.

PROTACs show promise for cancer treatment, but designing them effectively is challenging.

PROTACs have become a breakthrough in medicine by effectively targeting and degrading specific proteins to treat diseases.

Antibody treatments show promise for hair loss but need more research.

Researchers developed promising agents for prostate cancer imaging, with the best one showing high potential for clinical use.

The study developed a mouse model for Alopecia Areata that responds to treatment, useful for future research.

Anti-CD19 therapy may help treat SLE and NMOSD.

Blocking the Hedgehog pathway may help overcome drug resistance in multiple myeloma.

The document concludes that DAB389-IL2 is promising for treating refractory cutaneous T-cell lymphoma, but more research is needed on its effectiveness and side effect management.

Higher monocyte counts predict less effective adalimumab treatment in hidradenitis suppurativa patients.

Immunoadsorption successfully treated a man's resistant polymyositis.

Newly designed proteins can effectively degrade specific proteins in cells, offering a potential new therapy method.

Adalimumab helped control a child's severe eye disease when other treatments failed.

Cell membrane-coated nanoparticles could improve gene therapy by enhancing delivery and targeting of nucleic acids.

New treatments for relapsing multiple sclerosis are more effective and convenient but have higher risks of serious side effects.

TNFα and interleukin-1 blockers reduce skin inflammation from EGFR antibody therapy.

Biologic agents can be effective for rheumatic diseases but have risks like infections and require careful monitoring and patient information.

AI and new therapies show promise in medicine, especially for cancer and regenerative treatments.

ASLAN004 was safe and well-tolerated, supporting further development for treating certain diseases.

TNFα and interleukin-1 blockers reduce skin inflammation from EGFR antibody therapy.

The man was diagnosed with stage III multiple myeloma and treated to improve kidney function.

Peptide-based PROTACs show promise in targeting hard-to-treat proteins, especially for cancer therapy.

Mogamulizumab can cause hair loss and skin rashes.